These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34477811)

  • 1. Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome.
    Stackowicz J; Gaudenzio N; Serhan N; Conde E; Godon O; Marichal T; Starkl P; Balbino B; Roers A; Bruhns P; Jönsson F; Moguelet P; Georgin-Lavialle S; Broderick L; Hoffman HM; Galli SJ; Reber LL
    J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34477811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
    Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S
    J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nlrp3 inflammasome activation in macrophages suffices for inducing autoinflammation in mice.
    Frising UC; Ribo S; Doglio MG; Malissen B; van Loo G; Wullaert A
    EMBO Rep; 2022 Jul; 23(7):e54339. PubMed ID: 35574994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage of bacterial colonization of skin and the urticaria-like rash of NLRP3-mediated autoinflammatory syndromes through mast cell-derived TNF-α.
    Nakamura Y; Kambe N
    J Dermatol Sci; 2013 Aug; 71(2):83-8. PubMed ID: 23684246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
    Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
    Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Nakanishi H; Kawashima Y; Kurima K; Chae JJ; Ross AM; Pinto-Patarroyo G; Patel SK; Muskett JA; Ratay JS; Chattaraj P; Park YH; Grevich S; Brewer CC; Hoa M; Kim HJ; Butman JA; Broderick L; Hoffman HM; Aksentijevich I; Kastner DL; Goldbach-Mansky R; Griffith AJ
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7766-E7775. PubMed ID: 28847925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAPS and NLRP3.
    Booshehri LM; Hoffman HM
    J Clin Immunol; 2019 Apr; 39(3):277-286. PubMed ID: 31077002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome.
    Karasawa T; Komada T; Yamada N; Aizawa E; Mizushina Y; Watanabe S; Baatarjav C; Matsumura T; Takahashi M
    Elife; 2022 May; 11():. PubMed ID: 35616535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equally potent: Nlrp3 mutation in macrophages or neutrophils is sufficient to drive autoinflammation.
    Chen KW
    EMBO Rep; 2022 Nov; 23(11):e56091. PubMed ID: 36194522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies.
    Moltrasio C; Romagnuolo M; Marzano AV
    Front Immunol; 2022; 13():1007705. PubMed ID: 36275641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.
    Brydges SD; Broderick L; McGeough MD; Pena CA; Mueller JL; Hoffman HM
    J Clin Invest; 2013 Nov; 123(11):4695-705. PubMed ID: 24084736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-frequency mosaicism in cryopyrin-associated periodic fever syndrome: mosaicism in systemic autoinflammatory diseases.
    Nishikomori R; Izawa K; Kambe N; Ohara O; Yasumi T
    Int Immunol; 2019 Sep; 31(10):649-655. PubMed ID: 31185077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies.
    McGeough MD; Wree A; Inzaugarat ME; Haimovich A; Johnson CD; Peña CA; Goldbach-Mansky R; Broderick L; Feldstein AE; Hoffman HM
    J Clin Invest; 2017 Dec; 127(12):4488-4497. PubMed ID: 29130929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
    Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M
    PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome.
    Theodoropoulou K; Spel L; Zaffalon L; Delacrétaz M; Hofer M; Martinon F
    J Allergy Clin Immunol; 2023 Jan; 151(1):222-232.e9. PubMed ID: 36075321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria.
    Nakamura Y; Kambe N; Saito M; Nishikomori R; Kim YG; Murakami M; Núñez G; Matsue H
    J Exp Med; 2009 May; 206(5):1037-46. PubMed ID: 19364881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Prevalence of
    Theodoropoulou K; Wittkowski H; Busso N; Von Scheven-Gête A; Moix I; Vanoni F; Hengten V; Horneff G; Haas JP; Fischer N; Palm-Beden K; Berendes R; Heubner G; Jansson A; Lainka E; Leimgruber A; Morris M; Foell D; Hofer M
    Front Immunol; 2020; 11():877. PubMed ID: 32477355
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism.
    Mensa-Vilaro A; Teresa Bosque M; Magri G; Honda Y; Martínez-Banaclocha H; Casorran-Berges M; Sintes J; González-Roca E; Ruiz-Ortiz E; Heike T; Martínez-Garcia JJ; Baroja-Mazo A; Cerutti A; Nishikomori R; Yagüe J; Pelegrín P; Delgado-Beltran C; Aróstegui JI
    Arthritis Rheumatol; 2016 Dec; 68(12):3035-3041. PubMed ID: 27273849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.
    Ballbach M; Hall T; Brand A; Neri D; Singh A; Schaefer I; Herrmann E; Hansmann S; Handgretinger R; Kuemmerle-Deschner J; Hartl D; Rieber N
    J Innate Immun; 2016; 8(5):493-506. PubMed ID: 27351923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.